The translocation identified in B-cell lymphoma positions BCL-2 under the control of the immunoglobulin heavy-chain promoter, leading to massive BCL-2 over-expression and subsequent resistance to cell death. Here, BCL2 is linked to B-cell non-Hodgkin lymphoma.